MiNK Therapeutics's market cap is currently $39.06M. The company's EPS TTM is $-3.864; its P/E ratio is ―; MiNK Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 2.70B	$ 0.00	$ 0.00	$ 689.63K
Gross Profit	$ -204.62K	$ -28.24B	$ -28.36B	$ -55.06K	$ 689.63K
Operating Income	$ -22.92M	$ -30.95M	$ -28.36M	$ -14.64M	$ -22.28M
EBITDA	$ -22.25M	$ -30.83M	$ -27.70M	$ -13.74M	$ -22.20M
Net Income	$ -22.46M	$ -24.78M	$ -23.11M	$ -15.68M	$ -25.91M
Balance Sheet
Cash & Short-Term Investments	$ 3.37M	$ 19.64M	$ 38.89M	$ 2.69M	$ 299.04K
Total Assets	$ 4.55M	$ 21.47M	$ 40.24M	$ 4.56M	$ 1.31M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 43.82M	$ 26.79M
Net Debt	$ -3.37M	$ -19.64M	$ -38.89M	$ 41.13M	$ 26.49M
Total Liabilities	$ 22.61M	$ 21.87M	$ 16.47M	$ 58.43M	$ 37.64M
Stockholders' Equity	$ -18.06M	$ -401.30K	$ 23.78M	$ -53.87M	$ -36.33M
Cash Flow
Free Cash Flow	$ -15.84M	$ -19.12M	$ -13.08M	$ -8.43M	$ -15.37M
Operating Cash Flow	$ -15.76M	$ -18.87M	$ -12.83M	$ -8.34M	$ -14.94M
Investing Cash Flow	$ -73.56K	$ -250.05K	$ -248.98K	$ -95.21K	$ -426.47K
Financing Cash Flow	$ -407.17K	$ -155.60K	$ 49.26M	$ 11.11M	$ 11.44M

Currency in USD

MiNK Therapeutics Earnings and Revenue History

Income Statement >

MiNK Therapeutics Debt to Assets

Balance Sheet >

MiNK Therapeutics Cash Flow

Cash Flow >

MiNK Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing